Bath & Body Works' (BBWI) "Outperform" Rating Reiterated at Telsey Advisory Group

Key Points

• Bath & Body Works has received an "outperform" rating from Telsey Advisory Group with a price target of $38.00, indicating a potential upside of 27.75% from its current price.
• Analysts from various firms have adjusted their price targets for Bath & Body Works, with Goldman Sachs lowering theirs to $43.00, while Wells Fargo has raised theirs to $44.00.
• The company reported earnings of $0.37 EPS for the last quarter, beating expectations, and its fiscal year 2025 guidance is projected at 3.350-3.600 EPS.

Bath & Body Works (NYSE:BBWI - Get Free Report)'s stock had its "outperform" rating reaffirmed by equities researchers at Telsey Advisory Group in a note issued to investors on Thursday,Benzinga reports. They presently have a $38.00 price target on the stock. Telsey Advisory Group's price objective suggests a potential upside of 29.05% from the company's previous close.

Several other equities analysts have also recently issued reports on the stock. Morgan Stanley dropped their price objective on shares of Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating on the stock in a research note on Tuesday, May 6th. Barclays lowered their price target on shares of Bath & Body Works from $35.00 to $30.00 and set an "equal weight" rating on the stock in a research note on Friday, May 30th. Citigroup lowered their price target on shares of Bath & Body Works from $42.00 to $40.00 and set a "buy" rating on the stock in a research note on Tuesday, August 19th. Wall Street Zen cut shares of Bath & Body Works from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Finally, Wells Fargo & Company upped their price target on shares of Bath & Body Works from $40.00 to $44.00 and gave the stock an "overweight" rating in a research note on Wednesday, May 14th. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $41.62.

Bath & Body Works Trading Up 0.8%

BBWI stock traded up $0.24 on Thursday, hitting $29.45. The company's stock had a trading volume of 2,669,022 shares, compared to its average volume of 5,187,402. The firm has a 50 day moving average of $30.64 and a two-hundred day moving average of $30.69. Bath & Body Works has a 1 year low of $24.94 and a 1 year high of $41.87. The stock has a market cap of $6.07 billion, a price-to-earnings ratio of 8.72, a price-to-earnings-growth ratio of 0.98 and a beta of 1.49.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings results on Thursday, August 28th. The company reported $0.37 EPS for the quarter, meeting the consensus estimate of $0.37. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The firm had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.55 billion. During the same quarter in the prior year, the firm earned $0.37 EPS. Bath & Body Works's revenue for the quarter was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, equities analysts forecast that Bath & Body Works will post 3.3 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Bath & Body Works by 38.9% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 41,711 shares of the company's stock worth $1,265,000 after acquiring an additional 11,681 shares during the period. Kovitz Investment Group Partners LLC acquired a new stake in Bath & Body Works during the 4th quarter worth approximately $258,000. Merit Financial Group LLC acquired a new stake in Bath & Body Works during the 1st quarter worth approximately $714,000. Nuveen Asset Management LLC increased its position in Bath & Body Works by 3.7% during the 4th quarter. Nuveen Asset Management LLC now owns 764,195 shares of the company's stock worth $29,628,000 after purchasing an additional 27,136 shares in the last quarter. Finally, Assenagon Asset Management S.A. increased its position in Bath & Body Works by 3,642.2% during the 1st quarter. Assenagon Asset Management S.A. now owns 1,651,109 shares of the company's stock worth $50,062,000 after purchasing an additional 1,606,988 shares in the last quarter. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.